Total Funding
78
34
Total FundingCorporate Round raised
Growth Score 78 in past quarter
-16 pts
Heat Score 34 in past quarter
-47 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
68711
P-Cure is a biotech company that develops a patient-centric proton therapy solution with clinical benefits and financial advantages.
- Michael Marash: Founder & CEO
Neil Wyant: ChairmanPast Role: Everett Partners, Managing Director
About the Company
P-Cure is a biotech company that develops a patient-centric proton therapy solution with clinical benefits and financial advantages. P-Cure provides a compact 360-gantry-less adaptive proton therapy system that fits any radiation oncology department's existing infrastructure. P-Cure's integrated solution for simulating, planning,
positioning, and treating patients in the seated position will be optimal for delivering the maximum treatment dose to the tumor site while sparing healthy tissues and organs from treatment-related side effects.